Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OXYMAT is a Danish-origin manufacturer of on-site oxygen and nitrogen generation systems based on pressure swing adsorption technology. The company serves industrial markets broadly and also supplies MDR-approved medical oxygen generators for hospitals and healthcare facilities, where its systems provide continuous, high-purity oxygen produced on site. OXYMAT was founded in 1978 and operates with headquarters in Denmark and production, R&D, sales, and service functions in Slovakia. In 2022, the company was acquired by Atlas Copco and now operates as an Atlas Copco brand focused on engineered gas generation solutions. For healthcare, OXYMAT is best characterized as a commercial-stage medical device and infrastructure supplier rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OXYMAT.